Short answer
NEOGENOMICS INC (NEO) filed an 8-K current report with the SEC on July 20, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events). June 20, 2026 press release tied to a settlement agreement.
NEOGENOMICS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- June 20, 2026 press release tied to a settlement agreement
- Settlement disclosure may affect legal exposure, cash obligations, and investor assessment of ongoing risks
Item 8.01 · Other Events
- $9.813M civil settlement with DOJ resolving investigation into consulting services for healthcare providers
- Settlement follows voluntary 2021 OIG-HHS notification concerning federal healthcare-law compliance
- $11.2M reserve previously accrued as of March 31, 2026, exceeding the settlement payment
- Agreement includes neither company admission of liability nor government concession on claim merits
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other NEOGENOMICS INC 8-K filings
Get the next NEO 8-K as it lands
Follow NEO for push alerts, or ask the research agent what this filing means.